Dolphin Medical Services (BOM:526504) Debt-to-Equity: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:526504 Dolphin Medical Services Ltd BOM:526504
37 GF Score
Price ₹6.64
GF Value ₹2.59
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Dolphin Medical Services Debt-to-Equity?

Dolphin Medical Services's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0.00 Mil. Dolphin Medical Services's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ₹0.00 Mil. Dolphin Medical Services's Total Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Dolphin Medical Services's Debt-to-Equity or its related term are showing as below:

BOM:526504' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06   Med: 0.09   Max: 0.68
Current: 0.09

During the past 13 years, the highest Debt-to-Equity Ratio of Dolphin Medical Services was 0.68. The lowest was 0.06. And the median was 0.09.

BOM:526504's Debt-to-Equity is ranked better than
75.14% of 181 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.28 vs BOM:526504: 0.09

Dolphin Medical Services  (BOM:526504) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Dolphin Medical Services Debt-to-Equity Related Terms

Dolphin Medical Services Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Dolphin Medical Services's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dolphin Medical Services Debt-to-Equity Chart

Dolphin Medical Services Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.07 0.08 0.09 0.09

Dolphin Medical Services Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.08 N/A 0.09 N/A

BOM:526504 vs TMO, DHR, NTRA: Debt-to-Equity Comparison

For the Diagnostics & Research subindustry, Dolphin Medical Services's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dolphin Medical Services Debt-to-Equity vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dolphin Medical Services's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Dolphin Medical Services's Debt-to-Equity falls into.


BOM:526504
37GF Score
Dolphin Medical Services Ltd BOM:526504
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dolphin Medical Services Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Dolphin Medical Services's Debt to Equity Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 8.664) / 100.814
=0.09

Dolphin Medical Services's Debt to Equity Ratio for the quarter that ended in Jun. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Dolphin Medical Services (BOM:526504) Overvalued in 2026?

Based on GuruFocus' analysis, Dolphin Medical Services stock appears to be overvalued. The current stock price of ₹6.64 is trading 156.4% above its estimated GF Value™ of ₹2.59. GuruFocus considers Dolphin Medical Services to be Significantly Overvalued.

Key valuation signals for BOM:526504:

  • Debt-to-Equity: N/A
  • GF Value™: ₹2.59 vs. price of ₹6.64 (156.4% above fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the BOM:526504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dolphin Medical Services Business Description

Address Kovelamudivari Veedhi, D.No.29-28/1-27, Suryaraopet, Vijayawada, AP, IND, 520002
Dolphin Medical Services Ltd is engaged in providing diagnostics and other allied services. It includes a range of tests covering radiology and imaging, biochemistry, pathology, and microbiology. In addition, the company is also involved in Information Technology, Biotechnology, and Herbal sectors. Services provided by the company are Diagnostic Centre provides all the services under one roof; the Ophthalmic Laser Care Centre provides total laser eye treatment as "Dolphin Nethralaya"; Teleradiology Services; Clinical Trials and Life Sciences division; Medical Equipment & Goods associated distribution; Bio-Tech Division is to provide Foods and Herbal Products and Dolphin Electronic Solution and Technologies(DEST).
37GF Score

Get the complete analysis for BOM:526504

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹6.64
Price
₹2.59
GF Value